Diamonds and Dogs
8/3/15
Lexicon Pharmaceuticals, Inc. (LXRX)
Lexicon Pharmaceuticals' stock is running up over 50% today after announcing that its experimental drug showed promising results from its late-stage trial. The biopharmaceutical company has struggled in the past with clinical products, so today's news means this could be a potential turning point for the company. Now, Lexicon is filing an application with the FDA and is hoping for approval in 2016. Investors will be watching closely as the company looks to make a turnaround.
Linn Energy (LINE)
How much more of a beating can Linn Energy take? The oil and gas company has been a dog candidate for the last three days, and it has lost over 45% in value. Today, the stock is down 18% after RBC Capital Markets downgraded the stock from "Outperform" to "Sector Perform." Linn Energy has seen four downgrades within the last week, and has been absolutely crushed by investors. This makes us wonder if tomorrow could be a big day for the company, or another big loss.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.